Combined testing of troponin and copeptin at admission shows potential to save time and costs in acute care and for the entire hospital stay

 

A cost analysis among 713 patients with suspected acute myocardial infarction (AMI) revealed that the safe and early rule-out of AMI with one combined testing of cardiac troponin and copeptin at admission can significantly reduce length of stay for the patients in acute care (Emergency Department (ED)/Chest Pain Unit (CPU)), staff time and costs due to a lower number of medical procedures. Furthermore, overall hospital costs are significantly reduced in this group. These findings are enabled by a lower frequency of inpatient admissions, fewer medical procedures such as serial troponin measurements, and by the earlier identification and discharge in the ED of low-to-intermediate risk patients with suspected acute coronary syndrome (ACS).

“Symptoms of acute coronary syndrome are very common in every emergency department, but only 10% of these patients are actually diagnosed with AMI,” said Thomas Reinhold, principal investigator of BIC-8a and head of the Health Economics and Health System Research Unit of the Institute for Social Medicine, Epidemiology and Health Economics at Charité Berlin, Germany. “Our analysis demonstrates that incorporating copeptin testing into an early ACS management protocol in the ED saves cumulative costs in the acute care setting and the entire hospital stay, and confirms that such testing may add value for the healthcare system, making hospitals more efficient thereby saving hospital resources for the treatment of other severely ill patients.”

The analysis, “Cost analysis of early discharge using combined copeptin/cardiac troponin testing versus serial cardiac troponin testing in patients with suspected acute coronary syndrome,” was published in the August issue of PLOS One, based on the German subsample of the BIC-8 study1 and financial data of participating study sites.

BIC-8 is an interventional clinical trial conducted in leading German, Swiss and Austrian hospitals to demonstrate the safe discharge of suspected ACS patients with normal levels of troponin and copeptin at the first blood draw. A second study (cost analysis) considered clinical data taken from BIC-8 from an economic perspective. Combined, both studies suggest that early rule-out of AMI is safe and can directly translate into economic value for the entire hospital setting.

B·R·A·H·M·S Copeptin proAVP KRYPTOR assay is CE marked but not 510(k)-cleared and not available for sale in the U.S. Availability of product in each country depends on local regulatory marketing authorization status.

 




I want to grow my online platform to create awareness about ethical consumerism, environmentalism, and the plant-based lifestyle. My main mission is to share information that empowers people to make better choices and create a VEG NEW WORLD :)


Your support is vital and is helping me share the collected information with thousands of readers and viewers. I try to deliver exclusive stories and relevant content in a challenging commercial environment. Your contribution helps me to cover the costs that my service requires. Please consider contributing (no matter how small) to keep the information flowing so you can remain informed and have life changing interviews and stories to share.

Related articles

New Research Highlights the Impact of Lifestyle and Diet on Hematologic Care

Studies Highlight the Impact of Lifestyle, Diet, and Environment...

Celebrate the Vegans in Your Life with Thoughtful Holiday Delights Beyond Just Salad!

  Food Empowerment Project Launches Holiday Recipe Guide Featuring Veganized...

Top K-Beauty Brand ‘MDP+’ Debuts 4 New Products in the U.S. Market

  MEDIPEEL Expands U.S. Presence with Launch of Four Innovative...

Fill Your Stockings with Skincare Essentials!

  Pamper Her This Holiday Season with Thoughtful Skincare Stocking...
Betty Tűndik
Betty Tűndikhttps://vegnew.world
Hi everyone! Nice to e-meet you! Here are a few things you should know about me. I am a conscientious, open-minded, adaptable to new experiences, and ambitious Business Development Manager with a Bachelor's Degree in Economics - Banking, Finance, and Accountancy. Through my studies, I've also obtained many naturopathic and nutrition degrees as well. Part-time jobs have added marketing, network marketing, event management, and store management skills to my experience throughout my career. Throughout my career, I have also been a Hotel Manager and owned a Bar/Restaurant & Internet Cafe. My online marketing and social media interactivity experience was gained when I and my husband started a business with an online/organic webshop & healthy lifestyle consultancy. I've improved my English at Cambridge Academy of English - 2003, in Cambridge. I live a conscious lifestyle, and try to protect the ecosystem. Animal lover and capable of helping others without judgment or negative reactions, this is thanked my knowledge in holistic therapies and the naturopathy courses I've followed. I cannot leave for my spiritual growth and the continuous development in alternative and holistic therapies, so I'm learning at Kyron School of New Consciousness, receiving a Bio Energo-therapist diploma. Thanks to all my experiences I've decided to venture into publishing and writing, while also continuing to learn many new things daily. I hope you enjoy reading my hand-picked news and check back for my weekly articles.